Oncocross (382150)

KOSDAQ · 3,450 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

5,00010,000 H 12,790L 2,685 25.0826.0526.08
Mkt Cap
45.0B
Net Inc (2025)
-8.9B
PBR
3.37
52W
2K~12K

Oncocross operates in the Professional Services sector.

Legal name: Oncocross Co.,Ltd.

Net income was -8.9 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 45.0 billion KRW, with a P/B of 3.37.

These figures can be verified in the DART filing (receipt no. 20260716000447).

Financials

YearRevOp IncNet Inc
2025-8.9B
20241.1B-7.0B-6.5B
202392M-6.8B-4.2B

Full financials →

Checks

1 applicable out of 8 items

Check details →

Recent Filings

Semi-Annual Report (2026.06)

투자판단관련주요경영사항 (디지털 바이오뱅킹 구축을 위한 단백체 분석)

All filings →

Checks

1 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: No administrative designation criteria met.

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.1% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-14Semi-Annual Report (2026.06)
2026-07-30투자판단관련주요경영사항 (디지털 바이오뱅킹 구축을 위한 단백체 분석)